表紙
市場調查報告書

數位治療、健康:阻礙、革新、機會、預測

Digital Therapeutics & Wellness: Disruption, Innovation Opportunities & Forecasts 2019-2024

出版商 Juniper Research Ltd 商品編碼 629484
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
數位治療、健康:阻礙、革新、機會、預測 Digital Therapeutics & Wellness: Disruption, Innovation Opportunities & Forecasts 2019-2024
出版日期: 2019年05月15日內容資訊: 英文
簡介

本報告提供數位治療、健康技術選擇,主要市場區隔 (心血管疾病 & 高血壓,糖尿病 & 前糖尿病,肥胖 & 減重,戒煙,其他數位治療)的詳細的分析與預測,市場趨勢與機會,5年的市場規模預測等。

第1章 數位治療、健康:醫藥品的下個演進?

  • 簡介
  • 要點
  • 定義
  • 預測手法
  • 數位治療和醫藥品的未來
  • 健康的地方
  • Juniper的見解

第2章 數位治療、健康:市場情況

  • 簡介
  • 數位治療的開發
  • 治療 vs. 監測
  • 數位治療的範圍
  • 數位治療的阻礙評估
  • 健康應用的阻礙評估

第3章 數位治療、健康:價值鏈分析、收益預測

  • 數位治療、健康的價值鏈
  • 數位治療、健康的經營模式
  • 法規的展望
  • 數位治療的收益預測

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Overview

Juniper's new Digital Therapeutics & Wellness research provides an in-depth assessment of the evolving requirements, capabilities and market landscape of these disruptive technologies. This essential guide provides detailed analysis and forecasts for the following key segments:

  • Cardiovascular Disease & Hypertension
  • Diabetes & Prediabetes
  • Obesity & Weight Loss
  • Smoking Cessation
  • Other Digital Therapeutics
  • Digital Corporate Wellness
  • Consumer Wellness Apps

The research includes:

  • Market Trends & Opportunities (PDF)
  • 5-Year Market Sizing & Forecast Spreadsheet (Excel)

Key Features

  • Market Landscape: Strategic assessment of key trends and considerations for digital therapeutics players and investors; covering all aspects from product design and development to deployment and usage.
  • Benchmark Industry Forecasts: Forecasts providing adoption rates, subscription costs and total revenues for each of the following segments:
    • Cardiovascular Disease & Hypertension
    • Diabetes & Prediabetes
    • Obesity & Weight Loss
    • Smoking Cessation
    • Other Digital Therapeutics
    • Digital Corporate Wellness
    • Consumer Wellness Apps
  • Key Takeaways & Strategic Recommendations: Evaluation and strategic guidance on product development and factors affecting the use of digital therapeutics and wellness, segment by segment.
  • Juniper Disruptors & Innovators Quadrants: Analysis of key players in the digital therapeutics and wellness industries, including:
    • Cardiovascular Disease & Hypertension
      • Canary Health
      • Livongo
      • My mHealth
      • Omada
      • Proteus Digital Health
      • Vida Health
    • Diabetes & Prediabetes
      • Blue Mesa Health
      • Canary Health
      • Livongo
      • MapMyHealth
      • My mHealth
      • Virta
      • Voluntis
      • Welldoc
      • Wellthy Therapeutics
    • Smoking Cessation
      • 2Morrow
      • Click Therapeutics
      • Digital Therapeutics Inc
      • Nicotrax
      • Vida Health
    • Mental Health & Developmental Disorders
      • Akili Interactive Labs
      • AppliedVR
      • Big Health
      • Brain Power
      • Ginger.io
      • Meru Health
      • Pacifica
      • Pear Therapeutics
      • Tiatros
    • Wellness
      • 7Cups
      • Calm
      • Fitbit
      • GOQii
      • Limeade
      • Mindapps
      • Onlife Health
      • Sleepace
      • Somnox
      • Stop, Breathe & Think
      • Spotlight Six Software
      • The Mindfulness App
      • Welltok

Key Questions

  • 1. What effect will digital therapeutics have on healthcare?
  • 2. What conditions are best suited to digital therapeutics treatment?
  • 3. How do digital therapeutics and wellness interact?
  • 4. What are the main barriers to market access and monetisation for digital therapeutics and wellness?
  • 5. What are the strategies of the most successful players in the space?

Companies Referenced

Interviewed: 2Morrow, Akili Interactive Labs, Blue Mesa Health, Voluntis.

Case Studied: Calm, XpresSpa.

Included in Digital Therapeutics Disruptors & Challengers Quadrants: 2Morrow, Akili Interactive Labs, AppliedVR, Big Health, Blue Mesa Health, Brain Power, Canary Health, Click Therapeutics, Digital Therapeutics Inc, Ginger.io, Livongo, MapMyHealth, Meru Health, My mHealth, Nicotrax, Omada, Pacifica, Pear Therapeutics, Proteus, Silver Cloud, Tiatros, Vida Health, Virta Health, Voluntis, Welldoc, Wellthy Therapeutics.

Included in Digital Wellness Disruptors & Challengers Quadrant: 7Cups, Calm, Fitbit, GOQii, Headspace, Limeade, Mindapps, Onlife Health, Sleepace, Somnox, Spotlight Six Software, Stop, Breathe & Think, Welltok.

Mentioned:

Aetna, Apple, AstraZeneca, Aura, Cigna, Digital Therapeutics Alliance, FDA, Flex Digital Health, Garmin, Glytec, Huawei, Humana, Insight Timer, International Diabetes Foundation, John Hancock, Kickstarter, Magellan Healthcare, Medullan, Mindbliss, myStrength, NHS, NICE, Otsuka, Peerfit, Propeller Health, Thrive Global, Vitality, World Bank, World Health Organisation.

Table of Contents

1. Digital Therapeutics & Wellness: The New Treatment Economy

  • 1.1 Introduction
  • 1.2 Definitions
    • 1.2.1 Digital Therapeutics Definition
    • 1.2.2 Digital Wellness Definition
    • Figure 1.1: Digital Wellness & Digital Therapeutics Segment Overlap
  • 1.3 Research Scope
    • 1.3.1 Digital Therapeutics
    • 1.3.2 Wellness
  • 1.4 Forecast Methodologies
    • 1.4.1 Digital Therapeutics
    • Figure 1.2: Digital Therapeutics Forecast Methodology
    • 1.4.2 Consumer Digital Wellness
    • Figure 1.3: Consumer Digital Wellness Apps Forecast Methodology
    • 1.4.3 Corporate Digital Wellness
    • Figure 1.4: Corporate Digital Wellness Apps Forecast Methodology
  • 1.5 Digital Therapeutics & the Future of Medicine
    • 1.5.1 Requirements
    • Figure 1.5: Number of Published Digital Health Efficiency Studies over Time
    • 1.5.2 Limits of Digital Therapeutics
      • i. The Problem of Regulation
      • Figure 1.6: Steps from Test Tube to New drug Application Review
  • 1.6 Digital Wellness
    • 1.6.1 Digital Therapeutics & Wellness Apps
    • Figure 1.7: Pacifica for Clinicians Dashboard
    • Figure 1.8: Calm @ XpresSpa Store
    • Case Study: @ XpresSpa Partnership
  • 1.7 Market Outlook: Juniper's View
    • 1.7.1 The Future of Digital Therapeutics
      • i. Medical Validation & Path to Market
      • ii. The Portals & Integration Challenge
    • 1.7.1 The Future of Digital Therapeutics
      • i. Medical Validation & Path to Market
      • ii. The Portals & Integration Challenge
    • 1.7.2 Digital Therapeutics: Usage Forecasts
    • Figure & Table 1.9: Number of People Using Digital Therapeutics per annum (m), Split by 8 Key Regions, 2018-2024
    • 1.7.3 The Future of Wellness
    • 1.7.4 Digital Wellness: Adoption Forecasts
    • Figure & Table 1.10: Number of Digital Wellness Users per annum, Split by 8 Key Regions (m), 2019-2024

2. Digital Therapeutics Market Status

  • 2.1 Introduction
  • 2.2 Digital Therapeutics Development
  • Figure 2.1: Digital Therapeutics Development Timeline
    • 2.2.1 The Search for the 'Next Big Illness' & Competition
  • 2.3 Digital Therapeutics Value Chain
  • Figure 2.2: Digital Therapeutics Value Chain
  • 2.4 Digital Therapeutics Business Models
    • 2.4.1... for Digital Therapeutics Providers
      • i. Pressure for Results
      • ii. The Reimbursement Challenge
      • iii. Data Usage
    • 2.4.2...for Systems Integrators
      • i. User Interfaces & Software Design
    • 2.4.3... for the Consumer Market
    • 2.4.4... for Health Insurance Companies
      • i. New Offerings
      • ii. Acquisition or Integration?
  • 2.5 Digital Therapeutics Disruption Assessment
  • Figure 2.3: Juniper Strategy Quadrant for Digital Therapeutics
    • 2.5.1 Juniper's Disruptors & Challengers Quadrant Criteria
    • 2.5.2 Cardiovascular Disease & Hypertension Market Landscape & Outlook
      • i. Player Analysis & Positioning
      • Figure 2.4: Juniper Disruptors & Challengers Quadrant for Cardiovascular Disease & Hypertension
      • ii Cardiovascular Disease Digital Therapeutics Users forecast
      • Figure & Table 2.5: Disease & Hypertension digital Therapeutics Users per annum (m), Split by 8 Key Regions, 2019-2024
    • 2.5.3 Diabetes & Weight Loss Market Landscape & Outlook
      • i. Player Analysis & Positioning
      • Figure 2.6: Juniper Disruptors & Challengers Quadrant for Diabetes
      • ii. Diabetes Digital Therapeutics Users Forecast
      • Figure & Table 2.7: Diabetes digital therapeutics Users per annum (m), Split by 8 Key Regions, 2019-2024
      • iii. Weight Loss Digital therapeutics Users Forecast
      • Figure & Table 2.10: Smoking Cessation Digital therapeutics Users per annum (m), Split by 8 Key Regions, 2019-2024
    • 2.5.5 Mental Health & Developmental Disorders Market Landscape & Outlook
      • i. Player Analysis & Positioning
      • Figure 2.11: Juniper Disruptors & Challengers Quadrant for Mental Health & Development Disorders
      2.5.6 Other Digital Therapeutics forecast
    • Figure & Table 2.12: Other Digital Therapeutics Users per annum (m), Split by 8 Key Regions, 2019-2024

3. Digital Wellness Market Status

  • 3.1 Introduction
  • 3.2 Wellness Development
    • 3.2.1 Diversification
    • Figure 3.1: Thrive Global's Promoted Areas of Expertise
  • 3.3 Wellness Apps & Devices Value Chain
  • Figure 3.2: Digital Wellness Value Chain
  • Figure 3.2: Digital Wellness Value Chain
  • 3.4 Wellness App Business Models
    • 3.4.1 ... for Digital Wellness Software Providers
      • i. B2C Digital Wellness
      • Table 3.3: Mindfulness Pricing Scales
      • ii. B2B Digital Wellness
    • 3.4.2... for Digital Wellness Hardware Providers
    • 3.4.3... for Healthcare Insurers
  • 3.5 Digital Wellness Disruption Assessment
    • 3.5.1 Player Analysis & Positioning
    • Figure 3.4: Juniper Disruptors & Challengers Quadrant for Digital Wellness
      • i. Disruptors
      • ii. Catalysis
      • iii. Nascent
      • iv. Embryonic
      • Figure 3.5: Somnox Sleep Robot
  • 3.6 Digital Wellness forecast
    • 3.6.1 Digital Wellness Users Forecasts
    • Figure & Table 3.6: Number of Digital Wellness Users per annum, Split by 8 Key Regions (m), 2019-2024
    • 3.6.2 Digital Wellness Revenues
    • Figure & Table 3.7: Digital Wellness App Revenues per annum, Split by 8 Key Regions ($m), 2019-2024
Back to Top